OpenAlex
PricingAboutJobs
Log inGet started
Work

Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein

HTML

Year: 2010
Type: article
Source: Diabetes/Metabolism Research and Reviews
DOI: 10.1002/dmrr.1080
Authors: Wolfgang Glaesner, Andrew Mark Vick, Rohn Millican, Bernice Ellis, Sheng‐Hung Tschang, Yu Tian, Krister Bokvist, Martin Brenner, Anja Koester, Niels Porksen, Garret Etgen, Tom Bumol
Institution: Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glucagon-like peptide-1 analogues, GLP-1 receptor agonists, Fc fusion protein, IgG4, long-acting drugs, type 2 diabetes, insulinotropic effect, glucose-dependent insulin secretion, pharmacokinetics, glucose tolerance, weight loss, exenatide, Macaca fascicularis
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W1972057139
FWCI: 4.66
Cites: 24
Cited by: 315
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms